QCI Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

QCI Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,500	Closed	–	–	528
2020 Q1	$0	Hold	2,500	–	–	﹤0.01%	637
2019 Q4	$0	Hold	2,500	–	–	﹤0.01%	633
2019 Q3	$0	Hold	2,500	–	–	﹤0.01%	650
2019 Q2	$0	Hold	2,500	–	–	﹤0.01%	671
2019 Q1	$0	Hold	2,500	–	–	﹤0.01%	662
2018 Q4	$0	Hold	2,500	–	–	﹤0.01%	661
2018 Q3	$4K	Hold	2,500	–	–	﹤0.01%	525
2018 Q2	$4K	Hold	2,500	–	–	﹤0.01%	503
2018 Q1	$5K	Hold	2,500	–	–	﹤0.01%	514
2017 Q4	$6K	Hold	2,500	–	–	﹤0.01%	505
2017 Q3	$7K	Buy	+2,500	New	+$8.53K	﹤0.01%	435

QCI Asset Management's SGYP Position: Q2 2020 in Review

QCI Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2020, closing a stake of 2,500 shares.

QCI Asset Management first reported a position in SGYP in Q3 2017 and held it in 11 quarters. The position peaked at $7K in Q3 2017. 3 funds tracked by Wall St. Rank hold SGYP as of Q2 2020.

QCI Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2020 after selling out during the quarter.
QCI Asset Management sold 2,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2020.
QCI Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 11 quarters.
QCI Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $7K in Q3 2017.
3 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.